MENU

NVCT Nuvectis Pharma Forecast, Technical & Fundamental Analysis

Industry Biotechnology
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NVCT is expected to report earnings to rise 6.96% to -25 cents per share on March 11

Nuvectis Pharma NVCT Stock Earnings Reports
Q4'24
Est.
$-0.26
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.26
Q1'24
Beat
by $0.15
Q4'23
Est.
$-0.41
The last earnings report on November 05 showed earnings per share of -23 cents, beating the estimate of -25 cents. With 127.77K shares outstanding, the current market capitalization sits at 90.81M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Bridge Plaza
Phone
+1 201 614-3150
Employees
13
Web
https://www.nuvectis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

NVCT and Stocks

Correlation & Price change

A.I.dvisor tells us that NVCT and KRYS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and KRYS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
+4.93%
KRYS - NVCT
32%
Poorly correlated
+0.85%
RIGL - NVCT
29%
Poorly correlated
-3.61%
CSCI - NVCT
29%
Poorly correlated
-0.85%
PDSB - NVCT
28%
Poorly correlated
+1.29%
CELU - NVCT
27%
Poorly correlated
-4.76%
More